跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13 条关于
“radiotheranostics”
全部
13
临床试验
0
药物
1
机构
0
资讯
12
8个月前
Oncodesign Precision Medicine and Navigo Proteins Terminate Radiotheranostics Collaboration
11个月前
NUCLIDIUM Secures US Patent Protection for Copper-Based FAP-Targeting Radiotheranostics Platform
去年
Navigo Proteins and SCK CEN Partner to Advance Terbium-161 Based Radiotheranostics
12个月前
Nuclide Therapeutics Secures £5M to Advance ALDH1A1-Targeted Radiotheranostics for Therapy-Resistant Cancers
3个月前
Nuclidium Raises €115 Million to Advance Copper-Based Radiotheranostics for Prostate and Breast Cancer
去年
Nuclidium Raises $99M Series B to Advance Copper-Based Radiopharmaceutical Platform
去年
NUCLIDIUM's Copper-Based PET Tracer Shows Promise in Phase I/II Trial for Neuroendocrine Tumor Detection
去年
Starpharma Advances Dendrimer Drug Delivery Platform with Genentech Partnership and Clinical Progress
去年
NUCLIDIUM's Copper-Based Radiotracer Shows Enhanced Imaging Performance in First Prostate Cancer Patient
去年
Archeus Technologies and WARF Partner to Advance Novel Prostate Cancer Radiopharmaceutical ART-101 into Phase 1 Trials
第 1 页,共 2 页
上一页
下一页